A new study using an old, misunderstood technique -- hypnotic suggestion -- finds the brain can override responses experts have long assumed to be ingrained and automatic, such as reading. (Aug. 1, 2005)
A new Cornell study finds that it is primarily people whose ancestors came from places where dairy herds could be raised safely and economically, such as in Europe, who have developed the ability to digest milk. (June 1, 2005)
Vaccines that train the immune system to seek out and destroy malignant cells are at the cutting edge of cancer treatment. Now, joint research – conducted by researchers at Weill Medical Cornell and at the Ludwig Institute for Cancer Research Memorial Sloan-Kettering Cancer Center Branch in New York – has pinpointed two proteins that seem ideal targets for a vaccine against multiple myeloma.
For the first time, advanced neurological imaging suggests the brains of minimally conscious patients recognize and respond to speech in ways similar to healthy individuals, according to a team of researchers. (Feb. 7, 2005)
According to a new study by Cornell University food scientists, led by Rui Hai Liu, M.D., Ph.D., associate professor of food science, shallots, Western Yellow, pungent yellow and Northern Red onions are higher in anti-cancer chemicals than other varieties tested. (Oct. 7, 2004)
A substantial number of older persons are physically or mentally abused, and mistreated seniors are three times more likely to die within three years than those who are not abused, a study done for Cornell researchers.
For the first time, scientists have shown how the activity of a gene associated with normal human development, as well as the occurrence of cancer and several other diseases, is repressed epigenetically – by modifying not the DNA code of a gene, but instead the spool-like histone proteins around which DNA tightly wraps itself in the nucleus of cells in the body.
Previous attempts in mice to correct a rare inherited immune disorder, called Hyper IgM X-linked immunodeficiency, have failed because standard gene therapy raised risks for cancer. Now Weill Cornell Medical College researchers believe they've found a way around that problem.
